CEO Prof. Dr. Madeeha Malik has been selected as an expert of Pharmacy Practice for DRAP Pharmacovigilance Risk Assessment Expert Committee (PRAEC).
The committee will be responsible for assessing all aspects of risk management of therapeutics in the country.